Cargando…

Recent and current advances in PET/CT imaging in the field of predicting epidermal growth factor receptor mutations in non-small cell lung cancer

Tyrosine kinase inhibitors (TKIs) are a significant treatment strategy for the management of non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutation status. Currently, EGFR mutation status is established based on tumor tissue acquired by biopsy or resection, so there...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Na, Yan, Gang, Wu, Yuhui, Wang, Li, Wang, Yang, Xiang, Yining, Lei, Pinggui, Luo, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582655/ https://www.ncbi.nlm.nih.gov/pubmed/36276079 http://dx.doi.org/10.3389/fonc.2022.879341

Ejemplares similares

Correlations Study Between (18)F-FDG PET/CT Metabolic Parameters Predicting Epidermal Growth Factor Receptor Mutation Status and Prognosis in Lung Adenocarcinoma
por: Yang, Bin, et al.
Publicado: (2019)

Epidermal growth factor receptor mutations and brain metastases in non-small cell lung cancer
por: Zhao, Wei, et al.
Publicado: (2022)

Deep learning for predicting epidermal growth factor receptor mutations of non-small cell lung cancer on PET/CT images
por: Xiao, Zhenghui, et al.
Publicado: (2023)

The role of PET/CT in radiotherapy for nasopharyngeal carcinoma
por: Li, Hongjia, et al.
Publicado: (2022)

Use of (68)Ga-PSMA-11 and (18)F-FDG PET-CT Dual-Tracer to Differentiate Between Lymph Node Metastases and Ganglia
por: Shi, Yiping, et al.
Publicado: (2021)

Progress and Future Trends in PET/CT and PET/MRI Molecular Imaging Approaches for Breast Cancer
por: Ming, Yue, et al.
Publicado: (2020)

Performance of (18)F-FDG PET/CT Radiomics for Predicting EGFR Mutation Status in Patients With Non-Small Cell Lung Cancer
por: Zhang, Min, et al.
Publicado: (2020)

Radiomics Analysis of PET and CT Components of (18)F-FDG PET/CT Imaging for Prediction of Progression-Free Survival in Advanced High-Grade Serous Ovarian Cancer
por: Wang, Xihai, et al.
Publicado: (2021)

The Heterogeneous Metabolic Patterns of Ganglia in (68)Ga-PSMA, (11)C-choline, and (18)F-FDG PET/CT in Prostate Cancer Patients
por: Shi, Yiping, et al.
Publicado: (2021)

4D PET/CT as a Strategy to Reduce Respiratory Motion Artifacts in FDG-PET/CT
por: Chi, Alexander, et al.
Publicado: (2014)

A deep learning approach for automatic tumor delineation in stereotactic radiotherapy for non-small cell lung cancer using diagnostic PET-CT and planning CT
por: Yu, Xuyao, et al.
Publicado: (2023)

Tailoring the clinical management of colorectal cancer by (18)F-FDG PET/CT
por: Shi, Yang, et al.
Publicado: (2022)

Using combined CT-clinical radiomics models to identify epidermal growth factor receptor mutation subtypes in lung adenocarcinoma
por: Huo, Ji-wen, et al.
Publicado: (2022)

Identification of Stage IIIC/IV EGFR-Mutated Non-Small Cell Lung Cancer Populations Sensitive to Targeted Therapy Based on a PET/CT Radiomics Risk Model
por: Shao, Dan, et al.
Publicado: (2021)

Application of a combined radiomics nomogram based on CE-CT in the preoperative prediction of thymomas risk categorization
por: Dong, Wentao, et al.
Publicado: (2022)

The role of PET/CT in cervical cancer
por: Herrera, Fernanda G., et al.
Publicado: (2013)

Current concepts in F18 FDG PET/CT-based radiation therapy planning for lung cancer
por: Lee, Percy, et al.
Publicado: (2012)

Almonertinib plus chemotherapy versus almonertinib alone in second-line treatment of advanced non-small cell lung cancer with mutated epidermal growth factor receptor: a retrospective study
por: Fang, Xiaoxu, et al.
Publicado: (2023)

The Efficacy and Safety of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Thymosin in Advanced Non-Small Cell Lung Cancer Patients Harboring Active Epidermal Growth Factor Receptor Mutations
por: Feng, Yongdong, et al.
Publicado: (2021)

Evaluation of Epidermal Growth Factor Receptor 2 Status in Gastric Cancer by CT-Based Deep Learning Radiomics Nomogram
por: Guan, Xiao, et al.
Publicado: (2022)

The Role of the Metabolic Parameters of (18)F-FDG PET/CT in Patients With Locally Advanced Cervical Cancer
por: Wang, Dunhuang, et al.
Publicado: (2021)

Diagnostic Value of Delayed PET/MR in Liver Metastasis in Comparison With PET/CT
por: Zhou, Nina, et al.
Publicado: (2021)

Application of FDG-PET/CT in Radiation Oncology
por: Li, Jun, et al.
Publicado: (2013)

PET/CT in Multiple Myeloma: Beyond FDG
por: Matteucci, Federica, et al.
Publicado: (2021)

Choline PET/CT in recurrent prostate cancer
por: Detti, Beatrice, et al.
Publicado: (2023)

PET/CT Radiomic Features: A Potential Biomarker for EGFR Mutation Status and Survival Outcome Prediction in NSCLC Patients Treated With TKIs
por: Yang, Liping, et al.
Publicado: (2022)

Skeletal Metastasis as Detected by 18F-FDG PET with Negative CT of the PET/CT: Frequency and Impact on Cancer Staging and/or Management
por: Ahmed, Fatma, et al.
Publicado: (2016)

Pretherapeutic Assessment of Pancreatic Cancer: Comparison of FDG PET/CT Plus Delayed PET/MR and Contrast-Enhanced CT/MR
por: Zhang, Zaizhu, et al.
Publicado: (2022)

(18)F-FDG PET/CT radiomics nomogram for predicting occult lymph node metastasis of non-small cell lung cancer
por: Qiao, Jianyi, et al.
Publicado: (2022)

The Evolving Role of (18)F-FDG PET/CT in Diagnosis and Prognosis Prediction in Progressive Prostate Cancer
por: Shen, Kai, et al.
Publicado: (2021)

(18)F-FDG PET/CT radiomics for prediction of lymphovascular invasion in patients with early stage non-small cell lung cancer
por: Wang, Jie, et al.
Publicado: (2023)

Comparison of (68)Ga-FAPI and (18)F-FDG PET/CT in the Evaluation of Patients With Newly Diagnosed Non-Small Cell Lung Cancer
por: Wu, Junhao, et al.
Publicado: (2022)

Survival Outcomes of Patients With Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis
por: Li, Ning, et al.
Publicado: (2022)

Prognostic values of ALDOB expression and (18)F-FDG PET/CT in hepatocellular carcinoma
por: Jia, Wenzhi, et al.
Publicado: (2022)

A Nomogram Modeling (11)C-MET PET/CT and Clinical Features in Glioma Helps Predict IDH Mutation
por: Zhou, Weiyan, et al.
Publicado: (2020)

PET/CT in Radiotherapy Planning for Head and Neck Cancer
por: Newbold, Katie, et al.
Publicado: (2012)

Radioembolization and the Dynamic Role of (90)Y PET/CT
por: Pasciak, Alexander S., et al.
Publicado: (2014)

FAPI PET/CT in the Diagnosis of Abdominal and Pelvic Tumors
por: Yang, Tianshuo, et al.
Publicado: (2022)

Prediction of EGFR Mutation Status Based on (18)F-FDG PET/CT Imaging Using Deep Learning-Based Model in Lung Adenocarcinoma
por: Yin, Guotao, et al.
Publicado: (2021)

The combined role of PET/CT metabolic parameters and inflammatory markers in detecting extensive disease in small cell lung cancer
por: Hu, Yao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_85vauhc5367hfpqj7tu1em5jcg